HCW BIOLOGICS INC. - C
0.4400
07-10月-24 12:48:39
15 分の遅延
株式
-0.0105
-2.33%
本日の幅
0.4300 - 0.4510
ISIN
N/A
ソース
NASDAQ
-
U.S. Patent Issued to HCW Biologics for Foundational Platform Technology
03 8 2022 07:15:00 提供 Nasdaq GlobeNewswire
-
23 5 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights
13 5 2022 07:15:00 提供 Nasdaq GlobeNewswire
-
19 4 2022 07:33:00 提供 Nasdaq GlobeNewswire
-
28 3 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest
24 3 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
20 1 2022 08:00:03 提供 Nasdaq GlobeNewswire
-
19 1 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
HCW Biologics to Participate in H.C. Wainwright BioConnect Conference January 10 – 13, 2022
06 1 2022 07:33:00 提供 Nasdaq GlobeNewswire
-
HCW Biologics’ Founder and CEO Dr. Hing C. Wong Named Weaver H. Gaines Entrepreneur of the Year
13 12 2021 07:31:00 提供 Nasdaq GlobeNewswire
-
HCW Biologics Reports Third Quarter Financial Results and Recent Business Highlights
12 11 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
28 10 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
24 8 2021 07:32:00 提供 Nasdaq GlobeNewswire
-
17 8 2021 07:32:00 提供 Nasdaq GlobeNewswire
-
HCW Biologics Reports Second Quarter Financial Results and Recent Business Highlights
13 8 2021 07:10:00 提供 Nasdaq GlobeNewswire
-
HCW Biologics Inc. Announces Closing of $56.0 Million Initial Public Offering
22 7 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
HCW Biologics Inc. Announces Pricing of $56.0 Million Initial Public Offering
19 7 2021 18:39:57 提供 Nasdaq GlobeNewswire